STEP trial programme: difference between revisions
Diff·revision 11 → 12·06:02, 22 Nov 2024
Difference between revision 11 and revision 12 of STEP trial programme. 6 lines changed; the page grew by 113 bytes.
| Revision 11 — 07:43, 7 Nov 2024 TSH_Tallulah (talk) the percentage quoted was placebo-adjusted; label it 3,909 bytes +585 | Revision 12 — 06:02, 22 Nov 2024 DrTitration (talk) space between number and unit per PP:MOS 4,022 bytes +113 | ||
|---|---|---|---|
| 40 | <ref name="rubino2021">Rubino D, Abrahamsson N, Davies M, et al. "Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4)." ''JAMA'' 325(14):1414–1425 (2021). PMID 33755728.</ref> | 40 | <ref name="rubino2021">Rubino D, Abrahamsson N, Davies M, et al. "Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4)." ''JAMA'' 325(14):1414–1425 (2021). PMID 33755728.</ref> |
| 41 | 41 | ||
| + | 42 | == See also == | |
| + | 43 | * [[Semaglutide]] | |
| + | 44 | * [[SELECT trial]] | |
| + | 45 | * [[SUSTAIN trial programme]] | |
| + | 46 | * [[Placebo-adjusted effect]] | |
| + | 47 | ||
| 42 | {{DEFAULTSORT:STEP trial programme}} | 48 | {{DEFAULTSORT:STEP trial programme}} |
| 43 | [[Category:Clinical trial programmes]] | 49 | [[Category:Clinical trial programmes]] |